Contribution of annexin 2 to the architecture of mature endothelial adherens junctions

Mol Cell Biol. 2008 Mar;28(5):1657-68. doi: 10.1128/MCB.00695-07. Epub 2007 Dec 26.

Abstract

The vascular endothelial cadherin (VE-cad)-based complex is involved in the maintenance of vascular endothelium integrity. Using immunoprecipitation experiments, we have demonstrated that, in confluent human umbilical vein endothelial cells, the VE-cad-based complex interacts with annexin 2 and that annexin 2 translocates from the cytoplasm to the cell-cell contact sites as cell confluence is established. Annexin 2, located in cholesterol rafts, binds to both the actin cytoskeleton and the VE-cad-based complex so the complex is docked to cholesterol rafts. These multiple connections prevent the lateral diffusion of the VE-cad-based complex, thus strengthening adherens junctions in the ultimate steps of maturation. Moreover, we observed that the down-regulation of annexin 2 by small interfering RNA induces a delocalization of VE-cad from adherens junctions and consequently a destabilization of these junctions. Furthermore, our data indicate that the decoupling of the annexin 2/p11 complex from the VE-cad-based junction, triggered by vascular endothelial growth factor treatment, facilitates the switch from a quiescent to an immature state.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adherens Junctions / drug effects
  • Adherens Junctions / metabolism*
  • Annexins / metabolism*
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cadherins / metabolism
  • Cells, Cultured
  • Down-Regulation
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / cytology
  • Humans
  • Immunohistochemistry
  • Models, Biological
  • Precipitin Tests
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Thiazolidines / pharmacology
  • Time Factors
  • Transfection
  • Umbilical Veins / cytology
  • Vascular Endothelial Growth Factor A / pharmacology
  • beta-Cyclodextrins / pharmacology

Substances

  • Annexins
  • Bridged Bicyclo Compounds, Heterocyclic
  • Cadherins
  • RNA, Small Interfering
  • Thiazolidines
  • Vascular Endothelial Growth Factor A
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • latrunculin B